Weiwei Yu

机构：First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Peking University Shenzhen Hospital · ORCID：0000-0002-8914-5753

发表论文 82 篇 · 总被引 1036 次 · h-index 20

代表论文

• NAD+ rescues aging-induced blood-brain barrier damage via the CX43-PARP1 axis (2023 · Neuron · 被引 104)
• A Study on the Pathogenesis of Vascular Cognitive Impairment and Dementia: The Chronic Cerebral Hypoperfusion Hypothesis (2022 · Journal of Clinical Medicine · 被引 67)
• Effect of Dl-3-n-butylphthalide on mitochondrial Cox7c in models of cerebral ischemia/reperfusion injury (2023 · Frontiers in Pharmacology · 被引 24)
• RG-YOLO: multi-scale feature learning for underwater target detection (2024 · Multimedia Systems · 被引 22)
• General anaesthesia, the developing brain, and cerebral white matter alterations: a narrative review (2023 · British Journal of Anaesthesia · 被引 14)
• Connexin43 Contributes to Alzheimer’s Disease by Promoting the Mitochondria-Associated Membrane-Related Autophagy Inhibition (2024 · Molecular Neurobiology · 被引 13)